Global Biodegradable Hemostat Market Expansion at 10.9% CAGR, Valued at $1.48 Billion by 2029

Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.

What Are the Biodegradable Hemostat Market Size Forecast for 2025?
The market size for biodegradable hemostats has experienced striking growth in the past few years. From being valued at $0.88 billion in 2024, it is predicted to grow to $0.97 billion in 2025, attaining a compound annual growth rate (CAGR) of 11.2%. The significant growth observed in the historic period can be traced back to factors such as an increased understanding of postoperative complications, beneficial governmental policies, a rise in the prevalence of chronic illnesses such as cancer and heart diseases, expanding the number of hospital and surgical facilities, and the surge in investments towards healthcare infrastructure.

What Is the Market Size Outlook for Biodegradable Hemostat Until 2029?
Over the coming years, the biodegradable hemostat market is predicted to experience substantial expansion, with predictions suggesting it could reach a value of $1.48 billion by 2029, reflecting a compound annual growth rate (CAGR) of 10.9%. Several factors contributing to this growth during the projection period include the escalating number of surgical procedures globally, an increasing preference for biodegradable medical goods, a rise in trauma and accident cases, an ageing population, and an amplified need for minimally invasive operations. Furthermore, the anticipated trend influencers entail advancements in wound care technology, inventive breakthroughs in biodegradable materials, a growing demand for absorbable implants, enhancement of product packaging and distribution methods, and the creation of hybrid hemostats.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/biodegradable-hemostat-global-market-report

What Are the Major Factors Driving Demand in the Biodegradable Hemostat Market?
The rise in surgical procedures is believed to be a key factor contributing to the growth of the biodegradable hemostat market. Defined as medical procedures conducted by healthcare practitioners using specialized tools to address or eliminate body parts for health reasons, surgical procedures are primarily on the rise due to increasing chronic conditions, which frequently require surgical intervention for patient management and improved health results. Notably, the unique characteristic of biodegradable hemostats where they dissolve within the body after use, eliminating the need for extraction and reducing potential post-surgery complications, positions them as revolutionary tools in surgical procedures. Data from the British Association of Aesthetic Plastic Surgeons (BAAPS) in March 2023 reveal that there were 31,057 cosmetic procedures in 2022, marking a 102% increase from the previous year, with 93% of these procedures being performed on women, a 101% increase compared to 2021. Hence, the upsurge in surgical procedures is positively influencing the biodegradable hemostat market growth. The prevalence of trauma and accidents due to the increasing rate of road traffic incidents is another key factor expected to drive market growth for biodegradable hemostats. Trauma and accidents often result from sudden, external force-related events such as falls or impacts, typically requiring urgent medical intervention. The rise in trauma-related incidents and accidents is attributed to increased vehicle usage and swift urban development, which creates a riskier driving environment. This surge in trauma events fosters a high demand for biodegradable hemostats, as they offer quick control of severe bleeding and safely disintegrate within the body, making them highly beneficial in emergency and surgical scenarios. For example, Transport Canada reported in May 2024 that motor vehicle fatalities went up to 1,931 in 2022, marking a 6.0% rise from 1,821 deaths in 2021. Concurrently, severe injuries saw an 8.1% increase, rising from 8,185 in 2021 to 8,851 in 2022. Consequently, the surge in trauma and accident rates is propelling the growth of the biodegradable hemostat market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25706&type=smp

How Are End-Use Segments Shaping the Biodegradable Hemostat Market Outlook?
The biodegradable hemostat market covered in this report is segmented -

1) By Product Type: Natural Polymer-Based Hemostats, Synthetic Polymer-Based Hemostats, Composite Hemostats, Cellulose-Based Hemostats, Gelatin-Based Hemostats
2) By Formulation: Powdered Hemostats, Granular Hemostats, Liquid Hemostats, Foam Hemostats, Film Or Sheet Hemostats
3) By Application: Surgical Procedures, Trauma Procedures, Dental Procedures, Laparoscopic Procedures, Other Applications
4) By Distribution Channel: Direct Sales, Distributors, E-Commerce Platforms, Pharmaceutical Retailers, Healthcare Supply Companies
5) By End-User: Hospitals, Ambulatory Surgical Centers, Clinics, Research Laboratories, Other End Users

Subsegments:
1) By Natural Polymer-Based Hemostats: Collagen-Based, Chitosan-Based, Alginate-Based, Fibrin-Based, Dextran-Based
2) By Synthetic Polymer-Based Hemostats: Polyethylene Glycol (PEG)-Based, Polyurethane-Based, Polylactic Acid (PLA)-Based, Polyglycolic Acid (PGA)-Based, Polycaprolactone (PCL)-Based
3) By Composite Hemostats: Natural-Synthetic Polymer Blends, Polymer-Cellulose Composites, Polymer-Gelatin Composites, Multi-Layer Composites, Nano-Composite Hemostats
4) By Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC), Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Nanocellulose-Based, Hydroxypropyl Cellulose (HPC)
5) By Gelatin-Based Hemostats: Porcine Gelatin-Based, Bovine Gelatin-Based, Fish Gelatin-Based, Cross-Linked Gelatin, Modified Gelatin Formulations

What Are the Strategic Trends Transforming the Biodegradable Hemostat Market Landscape?
Significant corporations in the biodegradable hemostat market are honing in on the creation of innovative solutions like a plant-based cellulose matrix to swiftly manage hemorrhage and diminish blood loss. This plant-based cellulose matrix, a product organically derived from plant fibers, acts as a biodegradable scaffolding commonly employed in medical facilities due to its safety for absorption into the human body. On April 2024, for example, the medical device firm from the United States, LifeScience PLUS, introduced DonorSeal, an exceptional hemostatic bandage made entirely from plant-derived cellulose. Upon blood contact, DonorSeal becomes a gel that effectively ceases bleeding, offering biodegradability, absorbency, non-toxicity, and pH neutrality, making it safe for patients under anticoagulant medication. It also aids in fostering a damp and calming environment conducive for natural tissue restoration. Effortless removal of the dressing without causing wound resticking or reopening provides enhanced comfort and accelerated healing for donor site injuries.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25706&type=smp

Who Are the Prominent Companies in the Biodegradable Hemostat Market by ?
Major companies operating in the biodegradable hemostat market are Johnson & Johnson Services Inc., Medtronic Plc, Medline Industries LP, Becton, Dickinson and Co., Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Samyang Holdings Corp., Mölnlycke Health Care AB, GELITA Medical GmbH, B. Braun Melsungen AG, Tricol Biomedical Inc., Medtrade Products Limited, CryoLife Inc., Hemostasis LLC, Cura Medical, RevMedx Inc., Speed Care Mineral GmbH, Regenity, C. R. Bard Inc.

Which Region Is Expected to See the Highest CAGR in the Biodegradable Hemostat Market?
North America was the largest region in the biodegradable hemostat market in 2024. The regions covered in the biodegradable hemostat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Connect with us on:
Speak With Our Expert:
Saumya Sahay
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.